SDC1 and Miyoshi myopathy: In this study, we synthetized 64Cu- and 89Zr-labeled anti-CD138 antibodies that were able to detect subcutaneous MM tumors and bone marrow lesions with high sensitivity, outperforming 18F-FDG-PET in this preclinical model.